Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Tumor Control Following Stereotactic Radiosurgery in Patients with Vestibular Schwannomas - A Retrospective Cohort Study. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology Santa Maria, P. L., Shi, Y., Aaron, K. A., Gurgel, R. K., Corrales, C. E., Soltys, S. G., Santa Maria, C., Chang, S. D., Blevins, N. H., Jackler, R. K., Gibbs, I. C. 2021

Abstract

BACKGROUND: To better counsel vestibular schwannoma patients, it is necessary to understand the tumor control rates of stereotactic radiosurgery (SRS).OBJECTIVES: To determine tumor control rates, factors determining control and complication rates following SRS.METHODS: Tertiary hospital retrospective cohort.RESULTS: 579 tumors (576 patients) were treated with SRS. 477 tumors (474 patients, 82%) had =1?year follow up and 60% (344) =3?years follow up. 88% of tumors had primary SRS and 6.7% salvage SRS. Median follow up time was 4.6?years. At 3?years, the tumor control rate of primary SRS was 89% (258 of 290) in sporadic tumors compared to 43% in Neurofibromatosis type II (3 of 17) (p?

View details for DOI 10.1097/MAO.0000000000003285

View details for PubMedID 34353978